Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Lawrence

Showing results (781-790 of 884) with videos related to

Pageof 89
Sort By:
JAMA|June 7, 2006
Patient-reported symptoms and quality of life during treatment with tamoxifen or raloxifene for breast cancer prevention: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trialStephanie R Land, D Lawrence Wickerham, Joseph P Costantino, et al.
Clinical Trials (London, England)|January 22, 2013
National Surgical Adjuvant Breast and Bowel Project Study of Tamoxifen and Raloxifene trial: advancing the science of recruitment and breast cancer risk assessment in minority communitiesWorta McCaskill-Stevens, John W Wilson, Elise D Cook, et al.
Cancer Research|September 29, 1998
Frequency of prolonged remission duration after high-dose cytarabine intensification in acute myeloid leukemia varies by cytogenetic subtypeC D Bloomfield, D Lawrence, J C Byrd, et al.
Blood|December 31, 1997
Adult patients with de novo acute myeloid leukemia and t(9; 11)(p22; q23) have a superior outcome to patients with other translocations involving band 11q23: a cancer and leukemia group B studyK Mrózek, K Heinonen, D Lawrence, et al.
The New England Journal of Medicine|December 14, 2004
A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancerSoonmyung Paik, Steven Shak, Gong Tang, et al.
Molecular Microbiology|May 29, 2014
The structure, function and properties of sirohaem decarboxylase--an enzyme with structural homology to a transcription factor family that is part of the alternative haem biosynthesis pathwayDavid J Palmer, Susanne Schroeder, Andrew D Lawrence, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 7, 2012
Adjuvant tamoxifen reduces subsequent breast cancer in women with estrogen receptor-positive ductal carcinoma in situ: a study based on NSABP protocol B-24D Craig Allred, Stewart J Anderson, Soonmyung Paik, et al.
Journal of Chemotherapy (Florence, Italy)|November 28, 2006
Expression of genes related to activity of oxaliplatin and 5-fluorouracil in endoscopic biopsies of primary esophageal cancer in patients receiving oxaliplatin, 5-flourouracil and radiation: characterization and exploratory analysis with survivalL Leichman, D Lawrence, C G Leichman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 28, 1999
A Phase I study of raltitrexed, an antifolate thymidylate synthase inhibitor, in adult patients with advanced solid tumorsJ L Grem, J M Sorensen, E Cullen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 3, 2009
Menstrual cycle and surgical treatment of breast cancer: findings from the NCCTG N9431 studyClive S Grant, James N Ingle, Vera J Suman, et al.
Pageof 89

Showing results (781-790 of 884) with videos related to

Sort By:
Pageof 89
JAMA|June 7, 2006
Patient-reported symptoms and quality of life during treatment with tamoxifen or raloxifene for breast cancer prevention: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trialStephanie R Land, D Lawrence Wickerham, Joseph P Costantino, et al.
Clinical Trials (London, England)|January 22, 2013
National Surgical Adjuvant Breast and Bowel Project Study of Tamoxifen and Raloxifene trial: advancing the science of recruitment and breast cancer risk assessment in minority communitiesWorta McCaskill-Stevens, John W Wilson, Elise D Cook, et al.
Cancer Research|September 29, 1998
Frequency of prolonged remission duration after high-dose cytarabine intensification in acute myeloid leukemia varies by cytogenetic subtypeC D Bloomfield, D Lawrence, J C Byrd, et al.
Blood|December 31, 1997
Adult patients with de novo acute myeloid leukemia and t(9; 11)(p22; q23) have a superior outcome to patients with other translocations involving band 11q23: a cancer and leukemia group B studyK Mrózek, K Heinonen, D Lawrence, et al.
The New England Journal of Medicine|December 14, 2004
A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancerSoonmyung Paik, Steven Shak, Gong Tang, et al.
Molecular Microbiology|May 29, 2014
The structure, function and properties of sirohaem decarboxylase--an enzyme with structural homology to a transcription factor family that is part of the alternative haem biosynthesis pathwayDavid J Palmer, Susanne Schroeder, Andrew D Lawrence, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 7, 2012
Adjuvant tamoxifen reduces subsequent breast cancer in women with estrogen receptor-positive ductal carcinoma in situ: a study based on NSABP protocol B-24D Craig Allred, Stewart J Anderson, Soonmyung Paik, et al.
Journal of Chemotherapy (Florence, Italy)|November 28, 2006
Expression of genes related to activity of oxaliplatin and 5-fluorouracil in endoscopic biopsies of primary esophageal cancer in patients receiving oxaliplatin, 5-flourouracil and radiation: characterization and exploratory analysis with survivalL Leichman, D Lawrence, C G Leichman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 28, 1999
A Phase I study of raltitrexed, an antifolate thymidylate synthase inhibitor, in adult patients with advanced solid tumorsJ L Grem, J M Sorensen, E Cullen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 3, 2009
Menstrual cycle and surgical treatment of breast cancer: findings from the NCCTG N9431 studyClive S Grant, James N Ingle, Vera J Suman, et al.
Pageof 89